Press Releases

GlobeNewswire, Inc.

Treatment-related adverse events occurred in 1 of 12 ET-700 participants compared with 8 of 12 GALZIN® participants Hepatic copper uptake decreased 12% with ET-700, compared with a 46% decrease with GALZIN, and an 11% increase with placebo Company...

GlobeNewswire, Inc.

Press Release – No. 22 / 2026 Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results Copenhagen, Denmark, November 5, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ESO Solutions, Inc. (“ESO”), a leading data services and software provider for fire departments, EMS, hospitals, and government agencies, today announced the appointment of three associate chief...

GlobeNewswire, Inc.

Phase 3 SONATA-HCM study substantially overenrolled; top-line data expected Q1 2027 Positive STENO1 safety data strengthens benefit-risk profile for ZYNQUISTA® NDA resubmission Phase 1 clinical development of LX9851 ongoing by Novo Conference call...

GlobeNewswire, Inc.

First clinical data for sutacimig in Factor VII deficiency (FVIID) shows multi-fold accumulation of endogenous FVII(a) with shortening of prothrombin time after a single subcutaneous dose in initial participants of the Phase 2b study Preclinical...

GlobeNewswire, Inc.

Agreement builds on customer’s long-term deal in new Yokohama facility for five commercial biologics programs, now allocating an additional six commercial programs to Copenhagen facility to consolidate high-volume, single-use biologics...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report third quarter 2026 financial results and provide a business update on Thursday, November 12, 2026, before the open of the...

GlobeNewswire, Inc.

This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™ COPENHAGEN, Denmark, October 30, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a...

EIN Presswire

A practical reference for buyers evaluating wheel hub motor manufacturers in 2026. CALIFORNIA, CA, UNITED STATES, October 29, 2026 /⁨EINPresswire.com⁩/ -- China, Oct. 29, 2026 — Medical mobility designers are narrowing wheel hub motor choices...

GlobeNewswire, Inc.

November 5, 2026 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2026 Highlights Epcoritamab approved in Europe (as TEPKINLY®) and Japan (as EPKINLY®) in combination with R² for the treatment of adult patients with...

GlobeNewswire, Inc.

Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing the risk of death by 50% in patients with PD-L1...

MENAFN

(MENAFN) Hong Kong has moved to block poultry meat and poultry products from two outbreak zones, one in Denmark and one in the United States, as highly pathogenic bird flu spreads, according to a report by state media on Tuesday.

MENAFN

(MENAFN) Hong Kong has suspended imports of poultry meat and related products from specific areas of Denmark and the United States following outbreaks of bird flu, according to reports published Tuesday.

GlobeNewswire, Inc.

SYDNEY, AUSTRALIA, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that data from two...

South Carolina Governor's School for Science and Mathematics

The South Carolina Governor’s School for Science and Mathematics (GSSM) is proud to share that alumnus Dr. Vikhyat S. Bebarta (’90) has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health,...

Ministry of Foreign Affairs of the People's Republic of China

On October 19, Chinese Ambassador to Denmark H.E. Wang Xuefeng met with Mr. Mike Doustdar, Chief Executive Officer of Novo Nordisk.

EIN Presswire

Strengthening clinical expertise at the intersection of longevity medicine and precision diagnostics.

GlobeNewswire, Inc.

COPENHAGEN, Denmark – November 5, 2026. Novonesis delivered strong Q3 sales leading to 9M financial results at 7% organic sales growth and adjusted EBITDA margin of 37.9%. In addition, our 2026 outlook is confirmed at 7-8% organic sales growth...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data demonstrating early, sustained, and clinically meaningful improvements in kidney function in adults with hypoparathyroidism treated...

EIN Presswire

Acclaimed Industry Leaders from Over 20 Countries Unite to Judge the Year’s Most Outstanding Audio Storytelling NEW YORK, NEW YORK, NY, UNITED STATES, November 5, 2026 /⁨EINPresswire.com⁩/ -- The New York Festivals® Radio Awards®, celebrating 70...